IMMUNITYBIO INC (IBRX:NASDAQ)
$8.1 -0.1 (-1.2195%)
Analysed IMMUNITYBIO INC (IBRX:NASDAQ) News Sources
Jim Cramer Suggests Waiting for Clarity on ImmunityBio Before Taking a “Hard Look”
21-04-2026
yahoo.com
ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership
21-04-2026
yahoo.com
ImmunityBio (IBRX) Global Expansion Bolsters 266% Jump This Year
17-04-2026
yahoo.com
Assessing ImmunityBio (IBRX) Valuation After ANKTIVA Driven Q1 2026 Revenue Update
14-04-2026
yahoo.com
ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum
13-04-2026
yahoo.com
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
10-04-2026
yahoo.com
ImmunityBio Reports Net Product Revenue Increased Nearly 2.7 Times Year-Over-Year to Record $44 Million in Q1 2026 and $381 Million in Cash and Marketable Securities
09-04-2026
yahoo.com
IBRX Responds to FDA Warning Over Misleading Cancer Drug Claims
07-04-2026
yahoo.com
Is ImmunityBio’s (IBRX) FDA Promotion Setback Reframing the Stock’s Risk and Credibility Narrative?
07-04-2026
yahoo.com
Why ImmunityBio Stock Slumped on Monday
07-04-2026
fool.com
What is the current price of IMMUNITYBIO INC (IBRX:NASDAQ)?
The current price of IMMUNITYBIO INC (IBRX:NASDAQ) is $8.1.
IMMUNITYBIO INC (IBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNITYBIO INC (IBRX:NASDAQ) since the previous trading day is $-0.1.
IMMUNITYBIO INC (IBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNITYBIO INC (IBRX:NASDAQ) since the previous trading day is -1.2195%.
What is the most recent average sentiment score for IMMUNITYBIO INC (IBRX:NASDAQ)?
The most recent average sentiment score for IMMUNITYBIO INC (IBRX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for IMMUNITYBIO INC (IBRX:NASDAQ)?
The most recent sentiment for IMMUNITYBIO INC (IBRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNITYBIO INC (IBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.